We investigated the cellular mechanisms of the unique disorder of insulin action found in the polycystic ovary syndrome (PCOS). Approximately 50% of PCOS women (PCOS-Ser) had a significant increase in insulin-independent 13-subunit [32P]phosphate incorporation (3.7-fold, P < 0.05 vs other groups) in skin fibroblast insulin receptors that was present in serine residues while insulin-induced tyrosine phosphorylation was decreased (both P < 0.05 vs other groups). PCOS skeletal muscle insulin receptors had the same abnormal phosphorylation pattern. The remaining PCOS women (PCOS-nl) had basal and insulin-stimulated receptor autophosphorylation similar to control. Phosphorylation of the artificial substrate poly GLU4:TYR1 by the PCOS-Ser insulin receptors was significantly decreased (P < 0.05) compared to control and PCOS-nl receptors. The factor responsible for excessive serine phosphorylation appeared to be extrinsic to the receptor since no insulin receptor gene mutations were identified, immunoprecipitation before autophosphorylation corrected the phosphorylation defect and control insulin receptors mixed with lectin eluates from affected PCOS fibroblasts displayed increased serine phosphorylation. Our findings suggest that increased insulin receptor serine phosphorylation decreases its protein tyrosine kinase activity and is one mechanism for the post-binding defect in insulin action characteristic of PCOS. (J. Clin.
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We investigated the cellular mechanisms of the unique disorder of insulin action found in the polycystic ovary syndrome (PCOS). Approximately 50% of PCOS women (PCOS-Ser) had a significant increase in insulin-independent 13-subunit [32P] phosphate incorporation (3.7-fold, P < 0.05 vs other groups) in skin fibroblast insulin receptors that was present in serine residues while insulin-induced tyrosine phosphorylation was decreased (both P < 0.05 vs other groups). PCOS skeletal muscle insulin receptors had the same abnormal phosphorylation pattern. The remaining PCOS women (PCOS-nl) had basal and insulin-stimulated receptor autophosphorylation similar to control. Phosphorylation of the artificial substrate poly GLU4:TYR1 by the PCOS-Ser insulin receptors was significantly decreased (P < 0.05) compared to control and PCOS-nl receptors. The factor responsible for excessive serine phosphorylation appeared to be extrinsic to the receptor since no insulin receptor gene mutations were identified, immunoprecipitation before autophosphorylation corrected the phosphorylation defect and control insulin receptors mixed with lectin eluates from affected PCOS fibroblasts displayed increased serine phosphorylation. Our findings suggest that increased insulin receptor serine phosphorylation decreases its protein tyrosine kinase activity and is one mechanism for the post-binding defect in insulin action characteristic of PCOS. (J. Clin. Invest. 1995. 96:801-810.) Key words: insulin receptors . signal transduction * phosphoserine * polycystic ovary syndrome * insulin resistance 1. Abbreviations used in this paper: DGGE, denaturing gradient gel electrophoresis; hIR, human insulin receptor; NIDDM, non-insulin dependent diabetes mellitus; PCOS, polycystic ovary syndrome; PCOSnl, PCOS insulin receptorl(-subunits with phosphotyrosine and phosphoserine content similar to control; PCOS-Ser, PCOS insulin receptor (l-subunits with increased phosphoserine, decreased phosphotyrosine content.
Polycystic ovary syndrome (PCOS)' is probably the most common endocrine disorder of premenopausal women (1, 2) . This is a condition of unknown etiology characterized by hyperandrogenism, chronic anovulation and, frequently, substantial insulin resistance (1, 3, 4) . Obesity and PCOS have a synergistic negative impact on insulin action such that 20% of obese PCOS women have impaired glucose intolerance or non-insulin dependent diabetes mellitus (NIDDM) by their third decade (3, 4) . It can be extrapolated from these data that PCOS-related insulin resistance is an important cause of glucose intolerance in premenopausal women (5) . The cellular mechanisms of insulin resistance in PCOS, however, appear to differ from those in the other common insulin resistant states of obesity and NIDDM (6) . There is a striking shift to the right in the insulin doseresponse curve for glucose uptake in adipocytes, without changes in adipocyte insulin binding, greater than that seen with obesity alone (6, 7) . This defect is, in part, explained by a decrease in insulin-stimulated insulin receptor autophosphorylation (7) . There is also a more modest but significant decrease in maximal rates of insulin-mediated glucose uptake in adipocytes in PCOS (6) . This is secondary to decrease4 abundance of the insulin-regulatable GLUT4 glucose transporter (8) . Although caution must be exercised in extrapolating cellular mechanisms from in vivo dose-response curves, such studies suggest that similar defects are present in muscle, the major insulin target tissue (6) .
In NIDDM and in obesity many abnormalities in insulin action are secondary to hyperinsulinemia and hyperglycemia (9) (10) (11) (12) (13) . In contrast, in PCOS such defects are independent of glucose tolerance, insulin levels, and body fat topography (6, 8) . Some investigators have suggested that hyperandrogenism decreases insulin action (14, 15) . In our studies, circulating androgen levels have not been correlated with parameters of insulin sensitivity and we have found that suppression of hyperandrogenism achieved through "medical castration" with a long-acting GnRH analog does not alter insulin action in PCOS (3, 4, 6, 16) . However, other studies (17, 18) have suggested that androgens do contribute to insulin resistance in PCOS. Thus, it remains possible that defects in insulin action in PCOS represent acquired rather than intrinsic abnormalities. To investigate this possibility and to further assess the mechanisms of the post-binding defect in insulin receptor-mediated signal transduction, we examined insulin binding and receptor protein tyrosine kinase activity in cultured PCOS skin fibroblasts that had been removed from the in vivo environment for generations as well as in skeletal muscle. We have identified a novel abnor-residues, decreased insulin-dependent tyrosine autophosphorylation and decreased artificial substrate phosphorylation in 50% of PCOS women. Serine phosphorylation of the insulin receptor is postulated to be a mechanism for terminating insulin signaling (19) (20) (21) (22) . PCOS is thus the first insulin resistant state in which this mechanism appears to be operative.
Methods
Materials. DME, FBS, penicillin-streptomycin solution, and EDTA were obtained from Fisher Scientific (Pittsburgh, PA) Phosphate-free DME was obtained from GIBCO Tables I  and II) and control (4 obese and 4 nonobese), had participated in our previous studies of insulin action on glucose transport examined in isolated adipocytes (6, 8) . Two additional PCOS women and one control woman had muscle biopsies; these PCOS women had insulin resistance documented by euglycemic glucose clamp studies (6) Studies ofinsulin receptor autophosphorylation and protein tyrosine kinase activity. Skin fibroblasts were grown to confluence, serum-starved for 48 h and harvested in 10 mM Hepes, 1 mM EDTA, pH 7.4. After the addition of sucrose to 10% (wt/vol), the cells were lysed by nitrogen cavitation (20 min, 400 psi, 4°C) (cell disruption bomb, Par Instrument Co, Moline, IL) and the nuclei were separated by centrifugation at 1,000 g for 10 min at 4°C (27) . Plasma membranes were pelleted at 200,000 g for 60 min at 40C and stored at -700C. Before insulin receptor isolation, fibroblast membranes were washed first with 50 mM Hepes, 1 mM EDTA, pH 7.0 (buffer A) and then with buffer A containing 1.5 M NaCl (27) . Membranes then were solubilized in buffer A containing 2% Triton. For studies of insulin receptor protein kinase activity, insulin receptors were extracted directly from confluent serum-starved fibroblasts with 50 mM Hepes, 1 mM EDTA, 2 mM PMSF, 0.1 mg/ml aprotinin, 1% Triton, pH 7.4, at 40°for 1 h (28) . Extracts were then spun at 150,000 g for 1 h at 40C (28 Mixing experiments. The NIH 3T3 fibroblasts overexpressing the human insulin receptor (hIR) cDNA were grown to confluence and serum-starved as described above. Plasma membranes were prepared and hIRs were partially-purified by affinity chromatography on WGASepharose prior to further purification by immunoprecipitation with the anti-insulin receptor antibody, 18-44 as described above. Immunopurified hIRs were then mixed with WGA-Sepharose eluates from PCOS fibroblast membranes containing insulin receptors with increased phosphoserine-decreased phosphotyrosine (PCOS-Ser) or from control fibroblasts in a ratio of -10 fmol hIR:l fmol WGA-Sepharose insulin binding activity. Autophosphorylation in the presence and absence of 1 ,uM insulin was then performed as described above. Phosphorylated 13-subunits were excised from SDS gels and phosphoamino acid analysis was performed as outlined above.
In vivo fibroblast labeling. Control and PCOS-Ser fibroblasts (7-11th passage) were maintained in supplemented DME media as described above. Confluent cells were serum starved with DME containing 0.1% BSA for 48 h and pre-incubated in serum-free and phosphate-free DME media with 10 mM Hepes, pH 7.5 for 1 h at 37°C, labeled with 0.4 mCi/ml of [32P]orthophosphate for 4 h, and incubated in the presence and absence of 100 nM insulin for 10 min (33 Table II ). There appeared to be two groups of PCOS insulin receptors. Insulin receptors from seven of 14 PCOS women (50%) and one normal woman had increased basal autophosphorylation (> 60% of insulin-stimulated autophosphorylation) (Fig. 2) . The other 7 PCOS women had basal autophosphorylation (< 50% of insulin-stimulated phosphorylation) and insulinstimulated receptor autophosphorylation similar to receptors from control women (Fig. 2) . This was investigated a priori by re-establishing skin fibroblast cultures from these cell lines and performing additional studies with partially purified insulin receptors. In the PCOS insulin receptors with increased basal autophosphorylation (PCOS-Ser, n = 7), basal [32P]phosphate incorporation was increased significantly (3.7-fold, one-way ANOVA P < 0.001, P < 0.05 vs. other groups by Tukey's test) and there was minimal insulin-stimulated phosphorylation (Fig. 3) . In PCOS insulin receptors with normal basal autophosphorylation (PCOS-nl, n = 4), basal and insulin-stimulated [32P]phosphate incorporation was similar to that seen in control insulin receptors (Fig. 3 ). There were no significant correlations between parameters of receptor phosphorylation and insulin action in PCOS and control women. There were no significant differences in clinical characteristics or parameters of insulin (Figs. 3 and 4) . Insulin-independent phosphoserine content and insulin-dependent phosphotyrosine content were similar to control levels in PCOS-nl /3-subunits ( Fig. 3 and 4) . No phosphothreonine was detected. Immunoprecipitation after autophosphorylation confirmed that the abnormal pattern of phosphorylation was present in the insulin receptor /3-subunit (Fig. 1) . However, insulin induced (by spillover occupancy) similar patterns of [32P]phosphate incorporation in PCOS-Ser and control IGF-I receptors ( Fig. 1) and antiphosphotyrosine antibody immunoprecipitated similar amounts of /-subunit under these conditions to that immunoprecipitated by aIR-3 antibody (data not shown) suggesting that the PCOS-Ser IGF-I receptor tyrosine phosphorylated normally.
Insulin receptors partially-purified from PCOS skeletal muscle and immunoprecipitated after autophosphorylation had the same increased insulin-independent /-subunit [32P]phosphate incorporation and minimal further insulin-stimulated phosphorylation as that seen in PCOS skin fibroblast insulin receptors (Fig. 5) . Phosphoamino acid analysis revealed that this increased phosphate incorporation was into serine rather than tyrosine residues (data not shown). Insulin receptor /3-subunits phosphorylated in vivo in PCOS-Ser fibroblasts showed the same pattern of phosphorylation as that found in insulin receptors partially-purified from these cells and phosphorylated in vitro (data not shown). Patterns of insulin receptor autophos- (Fig. 6) . Maximal rates of substrate phosphorylation as well as the insulin-induced increment over basal were significantly decreased in PCOS-Ser compared to control and PCOS-nl insulin receptors (both one-way ANOVA P < 0.005, P < 0.05 vs other groups by Tukey's test, Fig. 6 ). Immunopurification and mixing studies. When partially purified insulin receptors were immunoprecipitated with anti-insulin receptor antibody, 18-44, before autophosphorylation, the amount of basal and insulin-stimulated [32P]phosphate incorporation into PCOS-Ser insulin receptors was similar to control (Table HI) . Both control and PCOS-Ser receptors had greater fold-stimulation of autophosphorylation after immunoprecipitation. This finding suggests that these isolated receptors did not contain increased amounts of insulin-independent phosphoserine. Mixing of immunopurified hIR with PCOS-Ser skin fibroblast WGA-Sepharose eluate resulted in increased insulin-independent /3-subunit phosphorylation on serine residues and decreased insulin-stimulated tyrosine phosphorylation as compared to hIR mixed with control skin fibroblast WGA-Sepharose eluate and to unmixed hIR (Fig. 7) . Insulin receptor gene sequencing. We have previously reported direct DNA sequencing of the insulin receptor gene in two of the PCOS-Ser women (subjects 6 and 8, Tables I and  II) autophosphorylationt1 tM insulin. Aliquots of partially-purified skeletal muscle insulin receptors from 2 PCOS-Ser and 2 control women containing equal amounts of protein (20,ug) were incubated in the presence or absence of 1 /sM insulin and the autophosphorylation reactions terminated after 30 min as described in Methods. The autophosphorylated receptors were immunoprecipitated and resolved by SDS-PAGE as described in Fig. 1 . There is increased basal autophosphorylation in both PCOS /-subunits and no further stimulation of phosphorylation by insulin (cpm basal/insulin 763/503, 967/901, respectively). In the control insulin receptors, there is minimal insulin-independent autophosphorylation and 10-14-fold insulin-stimulated phosphorylation (cpm basal/insulin 98/1414, 96/1036, respectively).
Insulin nM Figure 6 . Phosphorylation of poly GLU4:TYR1 by aliquots (5 pg protein) of partially-purified skin fibroblast insulin receptors at pH 7.4, in the presence of 0-100 nM insulin, *l-way ANOVA P < 0.005; PCOSSer < control and PCOS-nl, P < 0.05 Tukey's test. Skin fibroblast insulin receptors were directly extracted from confluent cell cultures, partially-purified, incubated in the presence of 0-100 nM and assays of the phosphorylation of poly GLU4:TYRI performed as outlined in The mechanisms for terminating the insulin signal have not been identified. However, serine phosphorylation of the insulin receptor in vivo and in cell-free systems has been shown to decrease the receptor's protein tyrosine kinase activity and may, thus, represent one mechanism for terminating insulin signaling (19-22, 36, 37) . Defects in insulin receptor autophosphorylation or substrate phosphorylation could result in the abnormalities of cellular insulin action characteristic of PCOS (6, 7). (38, 39) , it is probable that hybrid insulin/IGF-I receptors were present and that their phosphorylated /3-subunits were immunoprecipitated by both the anti-insulin receptor and the anti-IGF-I receptor antibodies (40, 41 Mix- ing PCOS-Ser WGA-eluates with a 10-fold excess of control hIR resulted in increased insulin-independent serine phosphorylation and decreased insulin-stimulated tyrosine phosphorylation of these insulin receptors. These results strongly suggest that the WGA-eluates contained a factor that was responsible for the excessive serine phosphorylation of the PCOS-Ser insulin receptors. This factor could be either a serine/threonine kinase or an inhibitor of a serine/threonine phosphatase (49) . Since the PCOS-Ser IGF-I receptors had [32P]phosphate incorporation similar to control, this suggests that the insulin receptor but not the IGF-I receptor was a substrate for this factor. Thus, serine residues unique to the insulin receptor /3-subunit may have been the sites of phosphorylation (50, 51) . Mapping of the /3-subunit phosphorylation sites will be necessary to investigate this hypothesis.
Candidate factors include an isoform of protein kinase C, a casein kinase I-like enzyme and cyclic AMP kinase (21, 52, 53) . There is extensive evidence indicating that protein kinase C can serine phosphorylate the insulin receptor (19) (20) (21) 50) . Further, the IGF-I receptor also appears to be a substrate for this kinase (55) . Alternatively, a novel factor may be responsible for the excessive serine phosphorylation. Insulin-stimulated serine phosphorylation of the insulin receptor also occurs and this appears to be secondary to intrinsic insulin receptor serine kinase activity (56, 57) . However, in the present study insulin receptor serine phosphorylation was insulin-independent and the serine phosphorylation factor was extrinsic to the receptor indicating that the receptor was not constituitively active.
Recent studies have identified an inhibitor of insulin receptor tyrosine kinase activity in WGA-eluates of skin fibroblasts from some insulin resistant subjects (58-60). This inhibitor, the membrane glycoprotein PC-1, differs from our putative serine phosphorylation factor in that it does not cause the increased basal [32P]phosphate incorporation characteristic of the serine phosphorylated PCOS-Ser insulin receptors (58, 60). Further, PC-1 appears to be a threonine-specific protein kinase (61) . Many, but not all, of the insulin resistant patients examined had increased PC-1 activity, similar to our finding that only 50% of PCOS women had increased insulin receptor serine phosphorylation. Other causes for insulin resistance must be sought in these individuals. Both studies, however, suggest an important role for factors extrinsic to the insulin receptor that regulate its kinase activity in the pathogenesis of human insulin resistance. This is the first report, to the best of our knowledge, of excessive insulin receptor serine phosphorylation associated with a human disorder of insulin action. However, it has been suggested that hyperglycemia induces insulin receptor serine phosphorylation causing a reversible component of insulin resistance in NIDDM (62, 63). Limited previous studies have found minimal phosphoserine in insulin receptor /-subunits from individuals with NIDDM (64, 65) . In contrast, we found a moderate amount of phosphoserine in control and PCOS-nl /3-subunits. Technical differences in the autophosphorylation conditions and reaction times may explain this observation since studies in cell lines overexpressing human insulin receptors have clearly shown that these receptors are serine phosphorylated under various conditions (21, 53, 57) . The presence of phosphoserine, in addition to phosphotyrosine, under normal circumstances raises the possibility that the insulin receptor may be under tonic inhibition by serine phosphorylation and that the factor responsible for this may be upregulated in PCOS-Ser cells. Serine dephosphorylation studies will be required to address this issue.
The presence of increased phosphoserine in hIR ,/-subunits after mixing with control lectin eluates suggests that the serine phosphorylation factor is present in normal human fibroblasts but not in murine fibroblasts (Fig. 7) .
The excessive serine phosphorylation appears to be a genetic defect since it persists in cultured cells (43) . Although skin fibroblasts are not classic insulin target tissues, abnormalities in insulin binding and receptor autophosphorylation identified in fibroblasts have reflected mutations in the insulin receptor gene (43) (44) (45) 47) . Moreover, we have also found increased phosphoserine and decreased phosphotyrosine in insulin receptors isolated from PCOS muscle, the major insulin target tissue. We hypothesize that the factor producing excessive insulin receptor serine phosphorylation is a likely locus for a mutation producing the insulin resistant state in affected PCOS women. Whether the decrease in adipocyte GLUT4 content (8) is an associated genetic defect or an acquired abnormality secondary to decreased insulin receptor-mediated signaling will require further study. There were no apparent phenotypic differences in the PCOS-Ser compared with the PCOS-nl women; both groups were insulin resistant, had Caucasian and Hispanic as well as lean and obese individuals. We hypothesize that the PCOS-nl women will have downstream defects in insulin receptor signaling since they have a similar biochemical phenotype to that of the PCOS-Ser women, i.e., a striking loss of insulin sensitivity (6, 7, 22) . PCOS is the first common insulin resistant state conferring an increased risk for NIDDM in which a specific and, potentially, intrinsic biochemical defect in insulin receptor signal transduction appears to be present (66).
